NEVVI Medicare utilization intelligence

← back

MURPHY, TIMOTHYMD NPI 1972591212 Clinician

Medical Oncology · COLORADO SPRINGS, CO

Specialty Medical Oncology — from billed Medicare claims
Trained HAHNEMAN MEDICAL COLLEGE OF THE PACIFIC — medical school, self-reported to CMS
In practice about 32 years since medical school (class of 1994, self-reported to CMS)
Location COLORADO SPRINGS, CO · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 60 codes billed · 35,463 disclosed volume (CY2024 — most recent year in data)
Current groups
Hospital affiliations
  • Hospital — CCN 060022
  • Hospital — CCN 060031
  • Hospital — CCN 061326
registry affiliations from the CMS Doctors & Clinicians facility file — an administrative affiliation, not a statement about where care is delivered

Group affiliation since 2019

20192026
ROCKY MOUNTAIN CANCER CENTERS LLP
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-10
Data year CY2024 CY2023 CY2022  CY2021  CY2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed submitted charges across all codes were in CY2024. Included with Platform.

  • Charge, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80053 Blood test, comprehensive group of blood chemicals
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
93793 Anticoagulant management of patient taking warfarin
82784 Gammaglobulin (immune system protein) measurement
96413 Administration of chemotherapy into vein, 1 hour or less
85610 Blood test, clotting time
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96372 Injection of drug or substance under skin or into muscle
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
J9217 Leuprolide acetate (for depot suspension), 7.5 mg

Showing the top 25 of 60 procedures this clinician billed. The full list is part of the premium platform. Notify me at launch →

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.